Xinru Li

863 total citations
38 papers, 605 citations indexed

About

Xinru Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinru Li has authored 38 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinru Li's work include Cancer-related Molecular Pathways (4 papers), Stroke Rehabilitation and Recovery (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Xinru Li is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Stroke Rehabilitation and Recovery (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Xinru Li collaborates with scholars based in China, United States and Netherlands. Xinru Li's co-authors include David G. Standaert, Yudong Liu, Hao Yu, Zhaoqi Yan, Gordon P. Meares, Jessica A. Buckley, Yufeng Li, Ashley S. Harms, Hongwei Qin and Etty Benveniste and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Scientific Reports.

In The Last Decade

Xinru Li

34 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinru Li China 12 243 100 94 78 62 38 605
Vishal Chavda India 15 204 0.8× 57 0.6× 50 0.5× 68 0.9× 50 0.8× 67 778
Cristiano Farace Italy 16 253 1.0× 71 0.7× 95 1.0× 145 1.9× 77 1.2× 26 941
Yun Xu China 15 358 1.5× 182 1.8× 107 1.1× 56 0.7× 49 0.8× 27 826
Xin Yi China 15 194 0.8× 57 0.6× 67 0.7× 34 0.4× 68 1.1× 42 667
Yifeng Du China 15 212 0.9× 78 0.8× 75 0.8× 149 1.9× 72 1.2× 36 653
Xiaojing Sun China 17 275 1.1× 68 0.7× 77 0.8× 44 0.6× 60 1.0× 47 757
Zheng Jiang China 14 327 1.3× 138 1.4× 35 0.4× 70 0.9× 66 1.1× 25 731
Lanhai Lü China 14 307 1.3× 106 1.1× 66 0.7× 28 0.4× 76 1.2× 27 629
Xudong Zhao China 17 449 1.8× 102 1.0× 106 1.1× 135 1.7× 32 0.5× 53 924
Toshio Yawata Japan 14 265 1.1× 63 0.6× 128 1.4× 46 0.6× 58 0.9× 28 567

Countries citing papers authored by Xinru Li

Since Specialization
Citations

This map shows the geographic impact of Xinru Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinru Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinru Li more than expected).

Fields of papers citing papers by Xinru Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinru Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinru Li. The network helps show where Xinru Li may publish in the future.

Co-authorship network of co-authors of Xinru Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xinru Li. A scholar is included among the top collaborators of Xinru Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinru Li. Xinru Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Xiuping, Xiaoguang Qiao, Xinru Li, et al.. (2025). Lactoferrin-modified organic-inorganic hybrid mesoporous silica for co-delivery of levodopa and curcumin in the synergistic treatment of Parkinson's disease. Phytomedicine. 140. 156547–156547. 5 indexed citations
3.
Li, Xinru, et al.. (2025). Aging increases the phytotoxicity of polyethylene and polypropylene to Lactuca Sativa L. compared to original microplastics. Journal of Environmental Management. 383. 125423–125423. 3 indexed citations
4.
5.
6.
Shao, Xinxin, Yuandi Xi, Lijie Pan, et al.. (2024). The effectiveness of Tai Chi for patients with mild cognitive impairment: a systematic review and meta−analysis. Frontiers in Neuroscience. 18. 1467595–1467595. 3 indexed citations
7.
8.
9.
Li, Xinru, Chi Kong Li, Fuhong Miao, et al.. (2024). Genome assembly of Melilotus officinalis provides a new reference genome for functional genomics. BMC Genomic Data. 25(1). 37–37. 2 indexed citations
10.
Dong, Nuo, Rongjie Yang, Xinru Li, et al.. (2024). A covalent organic frameworks based sensor for adsorptive stripping voltammetric detection of nanomolar dopamine in living mouse brain. Sensors and Actuators B Chemical. 426. 137037–137037. 7 indexed citations
11.
12.
Li, Xinru, Yan Liu, Juan Liu, et al.. (2023). STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. Cell Death and Disease. 14(7). 454–454. 4 indexed citations
13.
Zheng, Mingjun, Yuexin Hu, Ouxuan Liu, et al.. (2023). Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing. Oxidative Medicine and Cellular Longevity. 2023. 1–22. 16 indexed citations
14.
15.
Liu, Juan, Xinru Li, Yubo Wang, et al.. (2023). Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways. International Journal of Molecular Sciences. 24(4). 3418–3418. 18 indexed citations
16.
Li, Xinru, et al.. (2022). Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer. Journal of Ovarian Research. 15(1). 96–96. 36 indexed citations
17.
Li, Xinru, Yi Zhu, Guonan Zhang, Jianming Huang, & Lixia Pei. (2021). The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials. Journal of Ovarian Research. 14(1). 42–42. 12 indexed citations
18.
Li, Xinru, et al.. (2021). Clinical and genetic findings in patients with congenital cataract and heart diseases. Orphanet Journal of Rare Diseases. 16(1). 242–242. 6 indexed citations
19.
Li, Xinru, Muhammad Adnan, Qian Hu, et al.. (2021). A systematic high-throughput phenotyping assay for sugarcane stalk quality characterization by near-infrared spectroscopy. Plant Methods. 17(1). 76–76. 18 indexed citations
20.
Li, Yiqi, Xinru Li, Jun Pu, et al.. (2018). c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer. Thyroid. 28(12). 1642–1654. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vishal Chavda Breakdown of academic impact, for papers by Cristiano Farace Breakdown of academic impact, for papers by Yun Xu Breakdown of academic impact, for papers by Xin Yi Breakdown of academic impact, for papers by Yifeng Du Breakdown of academic impact, for papers by Xiaojing Sun Breakdown of academic impact, for papers by Zheng Jiang Breakdown of academic impact, for papers by Lanhai Lü Breakdown of academic impact, for papers by Xudong Zhao Breakdown of academic impact, for papers by Toshio Yawata
Rankless by CCL
2026